Vascular Graft Tunneler-Standard Curve Mid Curve Full Curve Short Standard Curve Vascular Graft Tunneler Accessories
Thoratec Laboratories
FDA Clearance Information
The vascular graft tunneler was cleared by the FDA via the 510k pathway on September 22, 2000. It is manufactured by Thoratec Laboratories and classified as a Class 2 device.
What It Is
FDA-Cleared Indications
- Creation of subcutaneous tunnels for placement of vascular grafts.
- Use during vascular reconstruction procedures in which a graft must be routed through soft tissue.
Clinical Applications
- Creating a subcutaneous tunnel for a vascular graft during coronary artery bypass surgery.
- Routing graft material during peripheral vascular bypass or reconstruction.
- Helping position a graft for treatment of limb-threatening ischemia when surgical revascularization is planned.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- The product name includes standard, mid, full, and short curve configurations; the surgeon selects the curve and length based on the operative route and patient anatomy.
- It is a tunneling instrument, not the vascular graft itself, and must be compatible with the planned graft material and surgical technique.
- The instrument is used under direct surgical control; care is required to avoid injury to nerves, veins, arteries, or other structures along the tunnel.
- The FDA record does not establish MRI safety labeling for this instrument. MRI use should be determined from the current manufacturer instructions and the instrument's material composition.
- Cleaning, sterilization, inspection, and maintenance must follow the current manufacturer instructions for use. It is not an implant and is not intended to remain in the body.
Frequently Asked Questions
What are the clinical indications for the vascular graft tunneler?
The device is indicated for use in creating subcutaneous tunnels for vascular grafts in coronary artery bypass and limb-threatening ischemia surgeries.
What outcomes have been reported in clinical studies?
Studies report acceptable early and mid-term outcomes, with improved graft patency when used with drug-eluting stents and biosynthetic grafts.
What complications have been reported?
Reported complications include surgical risks such as infection and graft failure, though specific safety data for the tunneler is limited.